Moises Selman Selected Research

Pulmonary Fibrosis (Hamman Rich Syndrome)

04/2008	MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis.
03/2006	Membrane type-matrix metalloproteinases in idiopathic pulmonary fibrosis.
02/2004	Increased surfactant protein-A levels in patients with newly diagnosed idiopathic pulmonary fibrosis.
11/2003	Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis.
04/2003	A dark side of interferon-gamma in the treatment of idiopathic pulmonary fibrosis?
04/2002	Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans.

6	Pulmonary Fibrosis (Hamman Rich Syndrome) 04/2008 - 04/2002
2	Asthma (Bronchial Asthma) 07/2005 - 03/2005
1	Pulmonary Tuberculosis 12/2005

2	Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA 02/2004 - 11/2003
1	Biological Markers (Surrogate Marker)IBA 04/2008
1	Membrane-Associated Matrix MetalloproteinasesIBA 03/2006
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2005
1	Immunoglobulin E (IgE)IBA 07/2005
1	Albuterol (Salbutamol)FDA LinkGeneric 03/2005
1	Interferon-gamma (Interferon, gamma)IBA 04/2003
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 04/2002